Transarterial embolisation and transarterial chemoembolisation vs no intervention
Death during study period · people with liver metastases
It is very uncertain whether transarterial embolisation and transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).
1 finding from 1 review
- Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes onlyRR 0.88 [0.74, 1.06]1 study · 61 participantsVery low